Clinical trials
Recruiting Phase 3 trials in Ireland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 10 |
| 2023 | 9 |
| 2024 | 18 |
| 2025 | 35 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 94 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 14 |
| Takeda | 8 |
| Boehringer Ingelheim | 3 |
| GlaxoSmithKline | 3 |
| Alnylam Pharmaceuticals | 2 |
| AstraZeneca | 2 |
| Bristol-Myers Squibb | 2 |
| ETOP IBCSG Partners Foundation | 2 |
| Eli Lilly and Company | 2 |
| European Myeloma Network B.V. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 10 |
| Breast Neoplasms | 8 |
| Ovarian Neoplasms | 5 |
| Crohn Disease | 4 |
| Multiple Myeloma | 4 |
| Amyloidosis | 3 |
| Anemia | 3 |
| Colitis, Ulcerative | 3 |
| Lung Neoplasms | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
Trials
Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.